Skip to main content
Equibles

Tracy Woody

Esperion Therapeutics, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Tracy Woody

Esperion Therapeutics, Inc. reported in an 8-K filed June 15, 2023 that Tracy Woody was appointed Chairperson of the Compliance Committee of the Board, effective June 15, 2023.

“In connection with Mr. Berkowitz's resignation, the Board approved the appointment of current Board member Tracy Woody as Chairperson of the Compliance Committee of the Board, effective immediately.”
Esperion Therapeutics, Inc. Form 8-K, filed June 15, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Esperion Therapeutics, Inc.

    SEC 8-K

    Current

    2023-06-15–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Esperion Therapeutics, Inc.

Current role

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.